Blood Clots Linked To AstraZeneca, Johnson & Johnson Covid-19 Vaccines: What We Know

Team Latestly Apr 14, 2021 04:56 PM IST

US regulators have recommended stopping the use of Johnson & Johnson's COVID-19 vaccine, as they investigate rare blood clotting in six women. Johnson & Johnson also said it was stopping the rollout of its vaccine in Europe. The move comes after Europe's drug regulator earlier this month said it had found a possible link between AstraZeneca's COVID-19 vaccine & very rare blood clots in some adults who had received the shot. Britain's health regulator, meanwhile, has recommended people under the age of 30 to get an alternative COVID-19 vaccine, if possible, rather than the AstraZeneca jab. Watch the video to know more.

(The above story first appeared on LatestLY on Apr 14, 2021 04:56 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).

Tags

AstraZeneca AstraZeneca COVID-19 Vaccine Blood Clots Blot Clots COVID-19 Vaccine COVID-19 Vaccine Update Europe Johnson & Johnson Medicines and Healthcare products Regulatory Agency Moderna Oxford Pfizer UK UK health minister UK minister United Kingdom Vaccines

Follow us on News

You Might Also Like

UK Royal Mail Scandal: Managers Faked Deliveries To Receive Bonuses, Says Report

UK Shocker: 2 Men Kill Their Neighbour With Hammer After Argument Over Dustbin in Somerset, Arrested

UK Shocker: Derbyshire Man Dies After Doctors Misdiagnose His Lung Cancer for Anxiety, Give Him Medications for Stress Despite Victim Complaining About Chest Pains

UK: Students of Nottingham School Drink and Engage in Sex Acts During Skiing Trip, Principal Faces Ban for 'Failing' To Stop Them

Categories